Akouos

About:

Akouos is a biotechnology company focusing on restoring and preserving hearing.

Website: https://www.akouos.com/

Twitter/X: akouosinc

Top Investors: Fidelity, RA Capital Management, New Enterprise Associates, Cormorant Asset Management, Novartis Venture Fund

Description:

Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Total Funding Amount:

$163M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)akouos.com

Founders:

Manny Simons, Michael McKenna

Number of Employees:

101-250

Last Funding Date:

2020-03-03

IPO Status:

Public

Industries:

© 2025 bioDAO.ai